RYAN MCVAIGH: Open Payments
NPI 1083100408 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 29 payments from 12 companies in 2025. Trend: 2023 $910 · 2024 $476 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $169 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| Merck Sharp & Dohme LLC | 5 | $100 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Actelion Pharmaceuticals US, Inc. | 1 | $35 |
| BridgeBio Pharma, Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| PFIZER INC. | 1 | $21 |
Products named: REPATHA, LEQVIO, VERQUVO, LifeVest, JARDIANCE, UPTRAVI, Attruby, Kerendia.
Industry payments across NY — which companies pay providers there.
